Mark Cuban's latest prescription for success
The billionaire entrepreneur and owner of the Dallas Mavericks has launched the Cost Plus Drug Company, which aims to disrupt the half-trillion-dollar prescription drug market.
www.cbsnews.comHere are the latest broadly reported items about Mark Cuban and his pharmacy-related initiatives:
-
Mark Cuban Cost Plus Drug Company (CostPlusDrugs) continues to be cited as a transparent online pharmacy aiming to lower generic drug costs by cutting middlemen. Several outlets reference its ongoing growth, with millions of customers and expanded drug listings as of 2024–2025.[1][2]
-
Independent analyses and coverage through 2024–2025 have highlighted studies showing Medicare Part D savings when Cost Plus pricing is used, suggesting meaningful cost reductions for many commonly prescribed drugs.[1]
-
Public interest coverage remains focused on how Cost Plus Drug Company disrupts traditional pharmacy supply chains and PBMs, including its pricing philosophy and direct-to-consumer model.[2][1]
-
Related commentary through 2024–2025 points to broader health-care reform discussions where Cuban’s approach is used as a case study for price transparency and competition in the prescription drug market.[4][1]
-
There is ongoing media attention in 2025–2026 about how Cuban’s initiatives intersect with other health-tech moves and policy debates, including potential partnerships and expansion plans in the U.S. market.[3][8]
If you’d like, I can pull more focused, up-to-the-minute articles from a specific outlet (e.g., CBS News, Forbes, or Penn’s Leonard Davis Institute) or summarize key findings from a recent study on cost savings. I can also provide a short timeline of major milestones for Cost Plus Drug Company and its impact on drug pricing.